Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-28

Clinical Trial Update: Pediatric Down Syndrome Post-Approval Study [NA]

View source ↗

Summary

A post-approval pediatric study is evaluating the Inspire hypoglossal nerve stimulation system for obstructive sleep apnea in children with Down syndrome, and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inspire Hypoglossal Nerve Stimulation System (Hypoglossal nerve stimulator)

Snippet

Sponsor: Inspire Medical Systems, Inc. | Conditions: Pediatric Obstructive Sleep Apnea, Down Syndrome (DS) | NA | Status: RECRUITING